These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29615987)

  • 21. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete synthesis of the bicyclic ring of a mutacin analog with orthogonally protected lanthionine via solid-phase intracyclization.
    Kirichenko K; Hillman JD; Handfield M; Park JH
    J Pept Sci; 2019 Nov; 25(11):e3214. PubMed ID: 31721375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
    Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model.
    Tague AJ; Putsathit P; Hutton ML; Hammer KA; Wales SM; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG
    Eur J Med Chem; 2019 May; 170():203-224. PubMed ID: 30901686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile-associated diarrhea and colitis.
    Gerding DN; Johnson S; Peterson LR; Mulligan ME; Silva J
    Infect Control Hosp Epidemiol; 1995 Aug; 16(8):459-77. PubMed ID: 7594392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives on lantibiotic discovery - where have we failed and what improvements are required?
    Sandiford SK
    Expert Opin Drug Discov; 2015 Apr; 10(4):315-20. PubMed ID: 25697059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of the novel semisynthetic lantibiotic NVB333 in vitro and in experimental infection models.
    Boakes S; Weiss WJ; Vinson M; Wadman S; Dawson MJ
    J Antibiot (Tokyo); 2016 Dec; 69(12):850-857. PubMed ID: 27189121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon.
    Le Lay C; Fernandez B; Hammami R; Ouellette M; Fliss I
    Front Microbiol; 2015; 6():1020. PubMed ID: 26441942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.
    Li C; Teng P; Peng Z; Sang P; Sun X; Cai J
    ChemMedChem; 2018 Jul; 13(14):1414-1420. PubMed ID: 29768720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors.
    D'Atanasio N; Capezzone de Joannon A; Di Sante L; Mangano G; Ombrato R; Vitiello M; Bartella C; Magarò G; Prati F; Milanese C; Vignaroli C; Di Giorgio FP; Tongiani S
    PLoS One; 2020; 15(2):e0228509. PubMed ID: 32074119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
    Seiler P; Enderlin-Paput M; Pfaff P; Weiss M; Ritz D; Clozel M; Locher HH
    Antimicrob Agents Chemother; 2016 Jan; 60(1):628-31. PubMed ID: 26503650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic characterization of position one variants within the lantibiotic nisin.
    Lagedroste M; Reiners J; Smits SHJ; Schmitt L
    Sci Rep; 2019 Jan; 9(1):935. PubMed ID: 30700815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria.
    Iancu C; Grainger A; Field D; Cotter PD; Hill C; Ross RP
    Probiotics Antimicrob Proteins; 2012 Jun; 4(2):108-15. PubMed ID: 26781852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms.
    Field D; O' Connor R; Cotter PD; Ross RP; Hill C
    Front Microbiol; 2016; 7():508. PubMed ID: 27148197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
    Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
    J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
    Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.